SUPPORT CANADIANS LIVING WITH CANCER
Consolidation therapy for multiple myeloma
Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.
Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).
Research at the Canadian Centre for Applied Research in Cancer Control led to a new standard in leukemia testing.
Volunteers provide comfort and kindness
Thousands of Canadian Cancer Society volunteers work in regional cancer centres, lodges and community hospitals to support people receiving treatment.